{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:22:59Z","timestamp":1768440179239,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/76013\/2011"],"award-info":[{"award-number":["SFRH\/BD\/76013\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["FCT-UID\/4539\/2013 \u2013 COMPETE"],"award-info":[{"award-number":["FCT-UID\/4539\/2013 \u2013 COMPETE"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["COMPETE POCI-01-0145-FEDER-007440"],"award-info":[{"award-number":["COMPETE POCI-01-0145-FEDER-007440"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PAC\u2013MEDPERSYST"],"award-info":[{"award-number":["PAC\u2013MEDPERSYST"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-016428"],"award-info":[{"award-number":["POCI-01-0145-FEDER-016428"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["BIGDATIMAGE"],"award-info":[{"award-number":["BIGDATIMAGE"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centro 2020 FEDER","award":["CENTRO-01-0145-FEDER-000016"],"award-info":[{"award-number":["CENTRO-01-0145-FEDER-000016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00417-018-4153-z","type":"journal-article","created":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T23:29:17Z","timestamp":1539559757000},"page":"2341-2348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mitochondrial pathophysiology beyond the retinal ganglion cell: occipital GABA is decreased in autosomal dominant optic neuropathy"],"prefix":"10.1007","volume":"256","author":[{"given":"Ot\u00edlia C.","family":"d\u2019Almeida","sequence":"first","affiliation":[]},{"given":"In\u00eas R.","family":"Violante","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Quendera","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4364-6373","authenticated-orcid":false,"given":"Miguel","family":"Castelo-Branco","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"4153_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mcn.2012.08.004","volume":"55","author":"A Maresca","year":"2013","unstructured":"Maresca A, la Morgia C, Caporali L et al (2013) The optic nerve: a \u201cmito-window\u201d on mitochondrial neurodegeneration. Mol Cell Neurosci 55:62\u201376. \n                    https:\/\/doi.org\/10.1016\/j.mcn.2012.08.004","journal-title":"Mol Cell Neurosci"},{"key":"4153_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00401-016-1625-2","volume":"132","author":"P Yu-Wai-Man","year":"2016","unstructured":"Yu-Wai-Man P, Votruba M, Burt\u00e9 F et al (2016) A neurodegenerative perspective on mitochondrial optic neuropathies. Acta Neuropathol 132:789\u2013806. \n                    https:\/\/doi.org\/10.1007\/s00401-016-1625-2","journal-title":"Acta Neuropathol"},{"key":"4153_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/aos.13285","volume":"5","author":"P Liskova","year":"2016","unstructured":"Liskova P, Tesarova M, Dudakova L et al (2016) OPA1 analysis in an international series of probands with bilateral optic atrophy. Acta Ophthalmol 5:1\u20137. \n                    https:\/\/doi.org\/10.1111\/aos.13285","journal-title":"Acta Ophthalmol"},{"key":"4153_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1755-3768.1983.tb01424.x","volume":"61","author":"P Kjer","year":"1983","unstructured":"Kjer P, Jensen OA, Klinken L (1983) Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy. Acta Ophthalmol 61:300\u2013312. \n                    https:\/\/doi.org\/10.1111\/j.1755-3768.1983.tb01424.x","journal-title":"Acta Ophthalmol"},{"key":"4153_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/archopht.116.3.351","volume":"116","author":"M Votruba","year":"1998","unstructured":"Votruba M, Fitzke FW, Holder GE et al (1998) Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol 116:351\u2013358. \n                    https:\/\/doi.org\/10.1001\/archopht.116.3.351","journal-title":"Arch Ophthalmol"},{"key":"4153_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/brain\/awr330","volume":"135","author":"PA Williams","year":"2012","unstructured":"Williams PA, Piechota M, von Ruhland C et al (2012) Opa1 is essential for retinal ganglion cell synaptic architecture and connectivity. Brain 135:493\u2013505. \n                    https:\/\/doi.org\/10.1093\/brain\/awr330","journal-title":"Brain"},{"key":"4153_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1750-1172-7-46","volume":"7","author":"G Lenaers","year":"2012","unstructured":"Lenaers G, Hamel CP, Delettre C et al (2012) Dominant optic atrophy. Orphanet J Rare Dis 7:46. \n                    https:\/\/doi.org\/10.1186\/1750-1172-7-46","journal-title":"Orphanet J Rare Dis"},{"key":"4153_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/eye.2014.37","volume":"28","author":"P Yu-Wai-Man","year":"2014","unstructured":"Yu-Wai-Man P, Votruba M, Moore AT, Chinnery PF (2014) Treatment strategies for inherited optic neuropathies: past, present and future. Eye 28:521\u2013537. \n                    https:\/\/doi.org\/10.1038\/eye.2014.37","journal-title":"Eye"},{"key":"4153_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/brain\/awm335","volume":"131","author":"C Zanna","year":"2008","unstructured":"Zanna C, Ghelli A, Porcelli AM et al (2008) OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 131:352\u2013367. \n                    https:\/\/doi.org\/10.1093\/brain\/awm335","journal-title":"Brain"},{"key":"4153_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-004-0970-8","volume":"109","author":"S Bette","year":"2005","unstructured":"Bette S, Schlaszus H, Wissinger B et al (2005) OPA1, associated with autosomal dominant optic atrophy, is widely expressed in the human brain. Acta Neuropathol 109:393\u2013399. \n                    https:\/\/doi.org\/10.1007\/s00401-004-0970-8","journal-title":"Acta Neuropathol"},{"key":"4153_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","volume":"9","author":"A London","year":"2013","unstructured":"London A, Benhar I, Schwartz M (2013) The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol 9:44\u201353. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2012.227","journal-title":"Nat Rev Neurol"},{"key":"4153_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.neuroimage.2013.05.032","volume":"81","author":"OC d\u2019Almeida","year":"2013","unstructured":"d\u2019Almeida OC, Mateus C, Reis A et al (2013) Long term cortical plasticity in visual retinotopic areas in humans with silent retinal ganglion cell loss. Neuroimage 81:222\u2013230. \n                    https:\/\/doi.org\/10.1016\/j.neuroimage.2013.05.032","journal-title":"Neuroimage"},{"key":"4153_CR13","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00429-015-1002-2","volume":"221","author":"C Mateus","year":"2016","unstructured":"Mateus C, d\u2019Almeida OC, Reis A et al (2016) Genetically induced impairment of retinal ganglion cells at the axonal level is linked to extrastriate cortical plasticity. Brain Struct Funct 221:1767\u20131780. \n                    https:\/\/doi.org\/10.1007\/s00429-015-1002-2","journal-title":"Brain Struct Funct"},{"key":"4153_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-160067","volume":"54","author":"S Liu","year":"2016","unstructured":"Liu S, Ong Y-T, Hilal S et al (2016) The association between retinal neuronal layer and brain structure is disrupted in patients with cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis 54:585\u2013595. \n                    https:\/\/doi.org\/10.3233\/JAD-160067","journal-title":"J Alzheimers Dis"},{"key":"4153_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1001\/jamaneurol.2013.573","volume":"70","author":"S Saidha","year":"2013","unstructured":"Saidha S, Sotirchos ES, Oh J et al (2013) Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol 70:34\u201343. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2013.573","journal-title":"JAMA Neurol"},{"key":"4153_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0079-6123(08)01132-1","volume":"173","author":"Y Y\u00fccel","year":"2008","unstructured":"Y\u00fccel Y, Gupta N (2008) Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration. Prog Brain Res 173:465\u2013478. \n                    https:\/\/doi.org\/10.1016\/S0079-6123(08)01132-1","journal-title":"Prog Brain Res"},{"key":"4153_CR17","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1093\/brain\/awp119","volume":"132","author":"CC Boucard","year":"2009","unstructured":"Boucard CC, Hernowo AT, Maguire RP et al (2009) Changes in cortical grey matter density associated with long-standing retinal visual field defects. Brain 132:1898\u20131906. \n                    https:\/\/doi.org\/10.1093\/brain\/awp119","journal-title":"Brain"},{"key":"4153_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-016-0691-0","volume":"16","author":"J Lemos","year":"2016","unstructured":"Lemos J, Pereira D, Castelo-Branco M (2016) Visual cortex plasticity following peripheral damage to the visual system: fMRI evidence. Curr Neurol Neurosci Rep 16:1\u201317. \n                    https:\/\/doi.org\/10.1007\/s11910-016-0691-0","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4153_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/1566524015666150303003028","volume":"15","author":"R Gao","year":"2015","unstructured":"Gao R, Penzes P (2015) Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. Curr Mol Med 15:146\u2013167. \n                    https:\/\/doi.org\/10.2174\/1566524015666150303003028","journal-title":"Curr Mol Med"},{"key":"4153_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0079-6123(04)47009-5","volume":"147","author":"TK Hensch","year":"2004","unstructured":"Hensch TK, Fagiolini M (2004) Excitatory-inhibitory balance and critical period plasticity in developing visual cortex. Prog Brain Res 147:115\u2013124. \n                    https:\/\/doi.org\/10.1016\/S0079-6123(04)47009-5","journal-title":"Prog Brain Res"},{"key":"4153_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fncel.2010.00010","volume":"4","author":"A Sale","year":"2010","unstructured":"Sale A, Berardi N, Spolidoro M et al (2010) GABAergic inhibition in visual cortical plasticity. Front Cell Neurosci 4:10. \n                    https:\/\/doi.org\/10.3389\/fncel.2010.00010","journal-title":"Front Cell Neurosci"},{"key":"4153_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00417-012-2112-7","volume":"251","author":"A Reis","year":"2013","unstructured":"Reis A, Mateus C, Viegas T et al (2013) Physiological evidence for impairment in autosomal dominant optic atrophy at the pre-ganglion level. Graefes Arch Clin Exp Ophthalmol 251:221\u2013234. \n                    https:\/\/doi.org\/10.1007\/s00417-012-2112-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4153_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuroimage.2008.03.007","volume":"41","author":"E Geuze","year":"2008","unstructured":"Geuze E, Westenberg HGM, Heinecke A et al (2008) Thinner prefrontal cortex in veterans with posttraumatic stress disorder. Neuroimage 41:675\u2013681. \n                    https:\/\/doi.org\/10.1016\/j.neuroimage.2008.03.007","journal-title":"Neuroimage"},{"key":"4153_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K","volume":"11","author":"SE Jones","year":"2000","unstructured":"Jones SE, Buchbinder BR, Aharon I (2000) Three-dimensional mapping of cortical thickness using Laplace\u2019s equation. Hum Brain Mapp 11:12\u201332. \n                    https:\/\/doi.org\/10.1002\/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K","journal-title":"Hum Brain Mapp"},{"key":"4153_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","volume":"38","author":"J Ashburner","year":"2007","unstructured":"Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38:95\u2013113. \n                    https:\/\/doi.org\/10.1016\/j.neuroimage.2007.07.007","journal-title":"Neuroimage"},{"key":"4153_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pnmrs.2011.06.001","volume":"60","author":"NA Puts","year":"2012","unstructured":"Puts NA, Edden RA (2012) In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc 60:29\u201341. \n                    https:\/\/doi.org\/10.1016\/j.pnmrs.2011.06.001","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"key":"4153_CR27","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/jmri.24478","volume":"40","author":"RAE Edden","year":"2014","unstructured":"Edden RAE, Puts NAJ, Harris AD et al (2014) Gannet: a batch-processing tool for the quantitative analysis of gamma-aminobutyric acid\u2013edited MR spectroscopy spectra. J Magn Reson Imaging 40:1445\u20131452. \n                    https:\/\/doi.org\/10.1002\/jmri.24478","journal-title":"J Magn Reson Imaging"},{"key":"4153_CR28","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mrm.1910300604","volume":"30","author":"SW Provencher","year":"1993","unstructured":"Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672\u2013679. \n                    https:\/\/doi.org\/10.1002\/mrm.1910300604","journal-title":"Magn Reson Med"},{"key":"4153_CR29","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1080\/01621459.1986.10478363","volume":"82126255","author":"DC Hoaglin","year":"1987","unstructured":"Hoaglin DC, Iglewicz B (1987) Fine-tuning some resistant rules for outlier labeling. J Am Stat Assoc 82126255:1147\u20131149. \n                    https:\/\/doi.org\/10.1080\/01621459.1986.10478363","journal-title":"J Am Stat Assoc"},{"key":"4153_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","volume":"55","author":"JA Fraser","year":"2010","unstructured":"Fraser JA, Biousse V, Newman NJ (2010) The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol 55:299\u2013334. \n                    https:\/\/doi.org\/10.1016\/j.survophthal.2009.10.002","journal-title":"Surv Ophthalmol"},{"key":"4153_CR31","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1007\/s00415-015-7696-5","volume":"262","author":"MA Rocca","year":"2015","unstructured":"Rocca MA, Bianchi-Marzoli S, Messina R et al (2015) Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutations. J Neurol 262:1216\u20131227. \n                    https:\/\/doi.org\/10.1007\/s00415-015-7696-5","journal-title":"J Neurol"},{"key":"4153_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jns.2015.01.008","volume":"349","author":"A Roubertie","year":"2015","unstructured":"Roubertie A, Leboucq N, Picot MC et al (2015) Neuroradiological findings expand the phenotype of OPA1-related mitochondrial dysfunction. J Neurol Sci 349:154\u2013160. \n                    https:\/\/doi.org\/10.1016\/j.jns.2015.01.008","journal-title":"J Neurol Sci"},{"key":"4153_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/1073858406287661","volume":"12","author":"CV Ly","year":"2006","unstructured":"Ly CV, Verstreken P (2006) Mitochondria at the synapse. Neuroscientist 12:291\u2013299. \n                    https:\/\/doi.org\/10.1177\/1073858406287661","journal-title":"Neuroscientist"},{"key":"4153_CR34","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1038\/cddis.2011.117","volume":"2","author":"D Nguyen","year":"2011","unstructured":"Nguyen D, Alavi MV, Kim K-Y et al (2011) A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death Dis 2:e240. \n                    https:\/\/doi.org\/10.1038\/cddis.2011.117","journal-title":"Cell Death Dis"},{"key":"4153_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejphar.2012.10.032","volume":"698","author":"A Mehta","year":"2013","unstructured":"Mehta A, Prabhakar M, Kumar P et al (2013) Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol 698:6\u201318. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2012.10.032","journal-title":"Eur J Pharmacol"},{"key":"4153_CR36","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/brain\/aws368","volume":"136","author":"IR Violante","year":"2013","unstructured":"Violante IR, Ribeiro MJ, Edden RAE et al (2013) GABA deficit in the visual cortex of patients with neurofibromatosis type 1: genotype-phenotype correlations and functional impact. Brain 136:918\u2013925. \n                    https:\/\/doi.org\/10.1093\/brain\/aws368","journal-title":"Brain"},{"key":"4153_CR37","doi-asserted-by":"publisher","first-page":"15721","DOI":"10.1523\/JNEUROSCI.4426-09.2009","volume":"29","author":"RAE Edden","year":"2009","unstructured":"Edden RAE, Muthukumaraswamy SD, Freeman TCA, Singh KD (2009) Orientation discrimination performance is predicted by GABA concentration and gamma oscillation frequency in human primary visual cortex. J Neurosci 29:15721\u201315726. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4426-09.2009","journal-title":"J Neurosci"},{"key":"4153_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.cortex.2014.10.019","volume":"64","author":"MJ Ribeiro","year":"2015","unstructured":"Ribeiro MJ, Violante IR, Bernardino I et al (2015) Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1. Cortex 64:194\u2013208. \n                    https:\/\/doi.org\/10.1016\/j.cortex.2014.10.019","journal-title":"Cortex"},{"key":"4153_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3174\/ajnr.A2902","volume":"34","author":"LM Levy","year":"2013","unstructured":"Levy LM, Degnan AJ (2013) GABA-based evaluation of neurologic conditions: MR spectroscopy. Am J Neuroradiol 34:259\u2013265. \n                    https:\/\/doi.org\/10.3174\/ajnr.A2902","journal-title":"Am J Neuroradiol"},{"key":"4153_CR40","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1177\/1073858412438697","volume":"18","author":"Y Ben-Ari","year":"2012","unstructured":"Ben-Ari Y, Khalilov I, Kahle KT, Cherubini E (2012) The GABA excitatory\/inhibitory shift in brain maturation and neurological disorders. Neurosci 18:467\u2013486. \n                    https:\/\/doi.org\/10.1177\/1073858412438697","journal-title":"Neurosci"},{"key":"4153_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuroimage.2013.01.009","volume":"86","author":"CJ Stagg","year":"2014","unstructured":"Stagg CJ (2014) Magnetic resonance spectroscopy as a tool to study the role of GABA in motor-cortical plasticity. Neuroimage 86:19\u201327. \n                    https:\/\/doi.org\/10.1016\/j.neuroimage.2013.01.009","journal-title":"Neuroimage"},{"key":"4153_CR42","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.conb.2011.01.006","volume":"21","author":"PE Castillo","year":"2011","unstructured":"Castillo PE, Chiu CQ, Carroll RC (2011) Long-term plasticity at inhibitory synapses. Curr Opin Neurobiol 21:328\u2013338. \n                    https:\/\/doi.org\/10.1016\/j.conb.2011.01.006","journal-title":"Curr Opin Neurobiol"},{"key":"4153_CR43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/1545968314543652","volume":"29","author":"JU Blicher","year":"2015","unstructured":"Blicher JU, Near J, N\u00e6ss-Schmidt E et al (2015) GABA levels are decreased after stroke and GABA changes during rehabilitation correlate with motor improvement. Neurorehabil Neural Repair 29:278\u2013286. \n                    https:\/\/doi.org\/10.1177\/1545968314543652","journal-title":"Neurorehabil Neural Repair"},{"key":"4153_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/cdd.2012.128","volume":"20","author":"YE Kushnareva","year":"2013","unstructured":"Kushnareva YE, Gerencser AA, Bossy B et al (2013) Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity. Cell Death Differ 20:353\u2013365. \n                    https:\/\/doi.org\/10.1038\/cdd.2012.128","journal-title":"Cell Death Differ"},{"key":"4153_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ceca.2014.11.008","volume":"57","author":"L F\u00fcl\u00f6p","year":"2015","unstructured":"F\u00fcl\u00f6p L, Rajki A, Maka E et al (2015) Mitochondrial Ca2+ uptake correlates with the severity of the symptoms in autosomal dominant optic atrophy. Cell Calcium 57:49\u201355. \n                    https:\/\/doi.org\/10.1016\/j.ceca.2014.11.008","journal-title":"Cell Calcium"},{"key":"4153_CR46","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0006-8993(80)90618-6","volume":"181","author":"ME Sandoval","year":"1980","unstructured":"Sandoval ME (1980) Studies on the relationship between Ca2+ efflux from mitochondria and the release of amino acid neurotransmitters. Brain Res 181:357\u2013367. \n                    https:\/\/doi.org\/10.1016\/0006-8993(80)90618-6","journal-title":"Brain Res"},{"key":"4153_CR47","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00221-008-1509-3","volume":"192","author":"M Spolidoro","year":"2009","unstructured":"Spolidoro M, Sale A, Berardi N, Maffei L (2009) Plasticity in the adult brain: lessons from the visual system. Exp Brain Res 192:335\u2013341. \n                    https:\/\/doi.org\/10.1007\/s00221-008-1509-3","journal-title":"Exp Brain Res"},{"key":"4153_CR48","doi-asserted-by":"publisher","first-page":"250421","DOI":"10.1155\/2012\/250421","volume":"2012","author":"JF Maya-Vetencourt","year":"2012","unstructured":"Maya-Vetencourt JF, Baroncelli L, Viegi A et al (2012) IGF-1 restores visual cortex plasticity in adult life by reducing local GABA levels. Neural Plast 2012:250421. \n                    https:\/\/doi.org\/10.1155\/2012\/250421","journal-title":"Neural Plast"},{"key":"4153_CR49","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.bbadis.2016.03.010","volume":"1862","author":"MC S\u00e1daba","year":"2016","unstructured":"S\u00e1daba MC, Mart\u00edn-Estal I, Puche JE, Castilla-Cort\u00e1zar I (2016) Insulin-like growth factor 1 (IGF-1) therapy: mitochondrial dysfunction and diseases. Biochim Biophys Acta 1862:1267\u20131278. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2016.03.010","journal-title":"Biochim Biophys Acta"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-018-4153-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4153-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4153-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T19:10:12Z","timestamp":1571080212000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-018-4153-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4153"],"URL":"https:\/\/doi.org\/10.1007\/s00417-018-4153-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"assertion":[{"value":"30 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were approved by the local Institutional Review Board, and followed the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}